Pre‐emptive antifungal therapy vs empirical antifungal therapy
Adverse effects · people with cancer who have febrile neutropenia
1 finding from 1 review
- Pre‐emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer 2022 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 1074 participantsVery low